MabThera International Trial - MInT

History and Acknowledgements

1999

1st Investigator's meeting - Lugano, July

• Protocol draft by Michael Pfreundschuh, GHGNHLSG, Homburg, Germany
• CRF draft by David Ma, ALLG, Sydney, Australia
• "MInT" the name by David Ma
• Extensive proof-reading and comments by Nicole Jones, Roche Australia; C. Rudolph, Cottbus, Germany; Lorenz Trümper, GHGNHLSG, Homburg, Germany; Jan Samuellson, Roche Sweden; Janey Stone, ALLG, Melbourne

2nd Investigator's meeting - New Orleans, December

• Final protocol draft
• Logistic procedures (part II) for the intergroup setting by Torsten Gerike
• Launch of the MinT Web-site
• -Logo by T. Gerike

2000

• 1st patient entered by Charité, Berlin, Germany: 05/2000
• 1st patient from Sweden entered: 06/2000

1st Monitoring  meeting - Basel, August

3rd Investigator's meeting - Saarbrücken, September

• 1st patient from Switzerland entered: 11/2000

4th Investigator's meeting - San Fransico, December

2001

• 1st patient form Denmark: 1/2001
• 1st patient from Spain: 1/2001
• 1st patient from the UK BNLI: 1/2001
• 1st patient from Australia ALLG: 2/2001
• 1st patient from Austria: 2/2001
• 1st patient from Norway: 2/2001
• 1st patient from Italy: 4/2001